As of 19 Nov 2026, Vytalyou has raised $933K across 1 verified round on record (amounts in other currencies converted to USD); latest: ₹9 crore pre-A round, announced 30 Sep 2026.
Preventive healthcare company
vytalyou.comMumbai, IndiaHealthtechFounded 2025
29 sources · checked 33 times, last 5d ago
No source explicitly says the round was led; the roundup’s “Lead Investors” table conflicts with its narrative and the specific articles, which describe the investors as funding participants. The press-release source’s approximate valuation wording prevails over Rediff’s “about” and the roundup’s exact figure.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-A pre-Series A | $933K ~$1.1M to date ₹9 crore at approximately ₹33 crore valuation | 2026-09-30 | not stated | No recent discussion |
29 sources · checked 33 times, last 5d ago [ VERIFIED · CORRECTED ] read against 4 of 29 sources
No source explicitly says the round was led; the roundup’s “Lead Investors” table conflicts with its narrative and the specific articles, which describe the investors as funding participants. The press-release source’s approximate valuation wording prevails over Rediff’s “about” and the roundup’s exact figure. | ||||
VytalYou operates doctor-supervised preventive-longevity clinics that combine diagnostics, personalized IV and wellness therapies, and medical guidance to help people identify health risks early and improve long-term health.
VytalYou is trying to move care upstream by using an AI-based Predictive Longevity Evaluation and doctor-reviewed diagnostics to identify risks before symptoms and tailor preventive or regenerative interventions. Its ₹9 crore pre-Series A will fund expansion from its Powai base to a three-centre Mumbai network, while the company says it has already served close to 1,000 clients.
Also named as backers in company research: Chetan Jain of Pharma Dose, Ratan Jain of Venus Industries